| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8917 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8787 |
| P-glycoprotein Substrate | Substrate | 0.7659 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6765 |
| Non-inhibitor | 0.9144 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7515 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8046 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8165 |
| CYP450 2D6 Substrate | Non-substrate | 0.8980 |
| CYP450 3A4 Substrate | Substrate | 0.7343 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8530 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9185 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9418 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7704 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9217 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8687 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9582 |
| Non-inhibitor | 0.6257 |
| AMES Toxicity | Non AMES toxic | 0.8994 |
| Carcinogens | Non-carcinogens | 0.9568 |
| Fish Toxicity | High FHMT | 0.9871 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9519 |
| Honey Bee Toxicity | High HBT | 0.7945 |
| Biodegradation | Not ready biodegradable | 0.9674 |
| Acute Oral Toxicity | IV | 0.6176 |
| Carcinogenicity (Three-class) | Non-required | 0.4253 |